Lars Fjellbirkeland
- Consultant pulmonologist and associate university professor; MD, PhD
- +47 23072017
Publications 2024
Evaluation of sex inequity in lung-cancer-specific survival
Acta Oncol, 63, 343-350
DOI 10.2340/1651-226X.2024.27572, PubMed 38751329
Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends
Clin Lung Cancer, 25 (5), e221-e228.e3
DOI 10.1016/j.cllc.2024.04.002, PubMed 38692990
Distribution and characteristics of malignant tumours by lung lobe
BMC Pulm Med, 24 (1), 106
DOI 10.1186/s12890-024-02918-w, PubMed 38439038
Publications 2023
Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization
Acta Oncol, 62 (1), 1-7
DOI 10.1080/0284186X.2023.2172687, PubMed 36718556
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Ann Oncol, 34 (7), 578-588
DOI 10.1016/j.annonc.2023.04.005, PubMed 37100205
Publications 2022
Concordance between clinical and pathology TNM-staging in lung cancer
Lung Cancer, 171, 65-69
DOI 10.1016/j.lungcan.2022.07.014, PubMed 35926242
Publications 2021
Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer
Cancer Treat Res Commun, 29, 100477
DOI 10.1016/j.ctarc.2021.100477, PubMed 34700140
Publications 2020
Lung cancer: Improved prognosis presents capacity challenges
Tidsskr. Nor. Laegeforen., 140 (5), 432-434
[Lung cancer: Improved prognosis results in capacity challenges]
Tidsskr Nor Laegeforen, 140 (5)
DOI 10.4045/tidsskr.20.0014, PubMed 32238965
Reduced delays in diagnostic pathways for non-small cell lung cancer after local and National initiatives
Cancer Treat Res Commun, 23, 100168 (in press)
DOI 10.1016/j.ctarc.2020.100168, PubMed 32028190
Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population
Acta Oncol, 59 (4), 376-383
DOI 10.1080/0284186X.2019.1711167, PubMed 31920119
Publications 2019
Increase in curative treatment and survival of lung cancer in Norway 2001-2016
Eur J Epidemiol, 34 (10), 951-955
DOI 10.1007/s10654-019-00536-z, PubMed 31313073
Publications 2018
Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016
Lung Cancer, 122, 138-145
DOI 10.1016/j.lungcan.2018.06.003, PubMed 30032822
LUNG CANCER SCREENING
Tidsskr. Nor. Laegeforen., 138 (15), 1470
Publications 2015
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust
Acta Oncol, 55 (2), 149-55
DOI 10.3109/0284186X.2015.1062537, PubMed 26313507
Crash course - Respiratory system
Tidsskr. Nor. Laegeforen., 135 (5), 459
DOI 10.4045/tidsskr.14.1485
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage
Int J Cancer, 138 (6), 1350-60
DOI 10.1002/ijc.29875, PubMed 26421593
Lung cancer survival in Norway, 1997-2011: from nihilism to optimism
Eur Respir J, 47 (1), 275-87
DOI 10.1183/13993003.00650-2015, PubMed 26541525
Publications 2012
[Mutation testing for non-small-cell lung cancer]
Tidsskr Nor Laegeforen, 132 (8), 952-5
DOI 10.4045/tidsskr.11.1017, PubMed 22562326
Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations
J Thorac Oncol, 7 (9), 1471-3
DOI 10.1097/JTO.0b013e3182614a9d, PubMed 22895145
Publications 2005
A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance
Am J Respir Cell Mol Biol, 33 (6), 541-8
DOI 10.1165/rcmb.2004-0355OC, PubMed 16123394
Publications 2003
Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue
Am J Pathol, 163 (2), 533-42
DOI 10.1016/s0002-9440(10)63681-4, PubMed 12875973
Publications 2002
The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1
J Cell Biol, 157 (3), 493-507
DOI 10.1083/jcb.200109100, PubMed 11970960
Publications 1998
Non-small-cell lung carcinoma cells invade human bronchial mucosa in vitro
In Vitro Cell Dev Biol Anim, 34 (4), 333-40
DOI 10.1007/s11626-998-0010-4, PubMed 9590507
Invasiveness by lacZ transfected non-small-cell lung cancer cells into human bronchial tissues in vitro
Lung Cancer, 21 (1), 7-19
DOI 10.1016/s0169-5002(98)00037-3, PubMed 9792049
Nonadheshive stationary organ culture of normal human urinary bladder mucosa
Anticancer Res, 18 (6A), 3979-83
PubMed 9891434
A human in vitro model of bladder tumour cell invasion
Anticancer Res, 18 (6A), 3985-9
PubMed 9891435
Nonadhesive stationary organ culture of normal human urinary bladder mucosa
Anticancer Res., 18 (6A), 3979-3983
Publications 1996
Nonadhesive stationary organ culture of human bronchial mucosa
Am J Respir Cell Mol Biol, 15 (2), 197-206
DOI 10.1165/ajrcmb.15.2.8703475, PubMed 8703475
Publications 1995
Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture
Virchows Arch, 426 (2), 169-78
DOI 10.1007/BF00192639, PubMed 7757288
TUMOR FRAGMENT SPHEROIDS FROM HUMAN NON-SMALL-CELL LUNG-CANCER MAINTAINED IN ORGAN-CULTURE
Virchows Arch. Int. J. Pathol., 426 (2), 169-178
[Swimming-induced asthma]
Tidsskr Nor Laegeforen, 115 (17), 2051-3
PubMed 7644982
Svømmeindusert astma
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 115(1995)nr. 17, S. 2051-2053
BIBSYS 952650088
[Guidelines for understanding and treating chronic obstructive lung diseases. Institute for Pharmacotherapy]
Tidsskr Nor Laegeforen, 115 (6), 710-3
PubMed 7900132
Publications 1994
The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease
Respir Med, 88 (8), 599-607
DOI 10.1016/s0954-6111(05)80008-3, PubMed 7991885
Publications 1990
[Methods for administration of anti-asthma inhalation drugs]
Tidsskr Nor Laegeforen, 110 (16), 2092-5
PubMed 2368076